[
  [
    1,
    "1 Introduction"
  ],
  [
    2,
    "1.1 Objectives of the Survey"
  ],
  [
    2,
    "1.2 Scope and Structure"
  ],
  [
    1,
    "2 Background"
  ],
  [
    2,
    "2.1 Overview of Small Molecule Discovery"
  ],
  [
    2,
    "2.2 Traditional Methods in Small Molecule Discovery"
  ],
  [
    2,
    "2.3 Emergence of Deep Learning in Drug Discovery"
  ],
  [
    1,
    "3 Deep Learning Techniques for Small Molecule Discovery"
  ],
  [
    2,
    "3.1 Data Representation and Preprocessing"
  ],
  [
    3,
    "3.1.1 Molecular Fingerprints"
  ],
  [
    3,
    "3.1.2 Graph-Based Representations"
  ],
  [
    3,
    "3.1.3 Smiles Strings"
  ],
  [
    2,
    "3.2 Architectures and Models"
  ],
  [
    3,
    "3.2.1 Convolutional Neural Networks (CNNs)"
  ],
  [
    3,
    "3.2.2 Recurrent Neural Networks (RNNs)"
  ],
  [
    3,
    "3.2.3 Graph Neural Networks (GNNs)"
  ],
  [
    2,
    "3.3 Applications and Use Cases"
  ],
  [
    3,
    "3.3.1 Virtual Screening"
  ],
  [
    3,
    "3.3.2 De Novo Drug Design"
  ],
  [
    3,
    "3.3.3 Property Prediction"
  ],
  [
    1,
    "4 Challenges and Limitations"
  ],
  [
    2,
    "4.1 Data Availability and Quality"
  ],
  [
    2,
    "4.2 Model Interpretability"
  ],
  [
    2,
    "4.3 Computational Resources"
  ],
  [
    1,
    "5 Discussion"
  ],
  [
    2,
    "5.1 Current Trends"
  ],
  [
    2,
    "5.2 Future Directions"
  ],
  [
    2,
    "5.3 Ethical Considerations"
  ],
  [
    1,
    "6 Conclusion"
  ],
  [
    2,
    "6.1 Summary of Findings"
  ],
  [
    2,
    "6.2 Implications for Research and Practice"
  ]
]